1-3 of 3
Yoshiyuki Hizukuri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prediction of Clinical Response By Phased Variants in Circulating Tumor DNA (ctDNA) in the VALENTINE-PTCL01 Trial of Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL)

Neha Mehta-Shah, Steven Horwitz, Pier Luigi Zinzani, Stefan K. Barta, Makoto Yamagishi, David M. Kurtz, Gensuke Takayama, Yoshiyuki Hizukuri, Weiguo Feng, Ken C. N. Chang, Takaya Moriyama, Keiko Nakajima, Ai Inoue, Emmanuel Bachy
Journal: Blood
Blood (2024) 144 (Supplement 1): 4342.
https://doi.org/10.1182/blood-2024-207594
Published: 2024
Journal Articles

Highly Sensitive Detection Method Reveals Significant Anti-Tumor Activity of Valemetostat in Patients with Relapsed/Refractory Adult T Cell Leukemia

Gensuke Takayama, Yoshiyuki Hizukuri, Tomoyuki Fujioka, Kazuyuki Hashimoto, Kazumi Ito, Hironori Yamada, Makoto Yamagishi, Makoto Nakashima, Yutaka Suzuki, Yasuhito Nannya, Kaoru Uchimaru, Shinji Tsutsumi
Journal: Blood
Blood (2022) 140 (Supplement 1): 9304–9305.
https://doi.org/10.1182/blood-2022-165922
Published: 2022
Journal Articles

A Novel Combination Regimen of BET and FLT3 Inhibition for FLT3-ITD Acute Myeloid Leukemia

Lauren Lee, Yoshiyuki Hizukuri, Paul Severson, Ben Powell, PhD, Chao Zhang, PhD, Yan Ma, Maiko Narahara, Hiroyuki Sumi, PhD, Gideon Bollag, PhD, Mark J. Levis, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1373.
https://doi.org/10.1182/blood-2019-124030
Published: 2019